📋 Pre-TRT Baseline

What this panel can settle, and by what logic

Eleven markers, and the right way to read the list is as the monitoring contract you are about to sign. Testosterone therapy is usually indefinite, and every number below is one you will be measured against for as long as you stay on it. Four groups.

1. The two that can force you to stop. Hematocrit on the Complete Blood Count (CBC) with Differential, and PSA (Total + Free + % Free). Erythrocytosis is the commonest reason therapy is interrupted, and it is common: in a large cohort on testosterone, hematocrit passed 0.50 L/L in 11% and 0.52 L/L in 3.7% Madsen 2021. Both markers are managed on the change from baseline, which is why the baseline has to exist Basheer 2025.
2. The one that decides what kind of low testosterone you have. LH & FSH beside Total Testosterone: high LH is testicular, low or normal LH is central Livingston 2023. Exogenous testosterone suppresses LH within weeks, so this is a question with a deadline.
3. The ones that make the dose readable. SHBG (Sex Hormone-Binding Globulin) and Estradiol, Sensitive (LC/MS-MS). Free testosterone is calculated from total and SHBG, and the testosterone-to-estradiol ratio only means anything when estradiol came off a sensitive assay Swislocki 2024.
4. The ones that catch collateral drift. ApoB (Apolipoprotein B) beside the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), because ApoB tracked residual risk better than LDL cholesterol across 13,015 statin-treated adults over a median 8 years Johannesen 2021, plus IGF-1 (Insulin-like Growth Factor 1), TSH (Thyroid-Stimulating Hormone) and the Comprehensive Metabolic Panel (CMP).

What it cannot settle, and what would

It cannot tell you whether TRT will make you feel better. There is no baseline value that predicts symptomatic response, which is why hypogonadism is defined as symptoms PLUS a repeatedly low morning testosterone rather than as a number Livingston 2023. A man at 310 ng/dL with heavy symptoms and a man at 290 ng/dL with none are not the same case.

It cannot predict who will get erythrocytosis. The 11% figure is a population rate and there is no marker here that identifies which 11% Madsen 2021. What the baseline buys is early detection, not prophecy — which is why the Complete Blood Count (CBC) with Differential belongs at 3 and 6 months rather than annually Basheer 2025.

It cannot substitute for a semen analysis, and this is the omission with the longest shadow. Testosterone suppresses gonadotropins and with them spermatogenesis; recovery after stopping runs from months to years and no pre-treatment blood marker forecasts it Desai 2022. If children are possible, the semen analysis and the cryopreservation happen before the first injection, not after.

And one draw is not a baseline. Testosterone has real within-subject biological variation Itkonen 2024, so the honest baseline is two morning draws in the same fortnight, under the same conditions, at the same laboratory.

Draw conditions that decide whether the money is wasted

Everything here is about reproducibility rather than accuracy. A baseline that cannot be reproduced is not a baseline, it is a souvenir.

1. 7 to 10am, fasted, and use the same window forever. The diurnal fall in testosterone is large enough that a 4pm follow-up against a 7am baseline invents a decline that never happened Livingston 2023.
2. Same laboratory, same method, written down. Immunoassay and LC-MS/MS disagree on Total Testosterone, and estradiol in men needs the sensitive assay or the number is not worth carrying Swislocki 2024.
3. No hCG, clomiphene, enclomiphene or anastrozole for 6 weeks, and no anabolic steroid for at least 3 months — all of them move the exact 11 numbers you are trying to fix in place, and a suppressed LH & FSH from a past cycle looks identical to primary central hypogonadism Desai 2022.
4. No hard training for 48 hours, no biotin for 72 hours, no draw within 2 weeks of an illness. Each moves a different part of the panel, and together they account for most surprising baselines.

How you would know it answered your question, and what each pattern means next

A baseline has no ‘abnormal’ column. What it has is a set of thresholds that change the plan.

• Hematocrit above 0.48 L/L before starting: little headroom. Recheck the Complete Blood Count (CBC) with Differential at 3 and 6 months, and expect the conversation about dose, ester and donation earlier than most men have it Madsen 2021.
• PSA (Total + Free + % Free) above 4 ng/mL, or above 2.5 ng/mL under 50: assess before starting Basheer 2025.
• Total Testosterone under 300 ng/dL once: draw it again on a separate morning Itkonen 2024. If the second is normal, the question was never TRT.
• Low testosterone with low LH & FSH: central. Add Prolactin and Ferritin first — a prolactinoma and hemochromatosis both produce this and both have treatments that restore your own production Livingston 2023.
• ApoB (Apolipoprotein B) above 90 mg/dL at baseline: fix this before adding a therapy that moves HDL, so that a later change is attributable Johannesen 2021.

Sources read for these sections

• Livingston M, et al. Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management. Diagnostics (Basel) 2023 · PMID 38132234
• Basheer B, et al. Management of Adverse Effects in Testosterone Replacement Therapy. International Braz J Urol 2025 · PMID 39908204
• Madsen MC, et al. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years. Journal of Clinical Endocrinology and Metabolism 2021 · PMID 33599731
• Desai A, et al. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS). Therapeutic Advances in Urology 2022 · PMID 35783920
• Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology 2021 · PMID 33736827
• Itkonen O, et al. The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. Clinica Chimica Acta 2024 · PMID 38341016
• Swislocki ALM, et al. A Review on Testosterone: Estradiol Ratio-Does It Matter, How Do You Measure It, and Can You Optimize It?. World Journal of Men's Health 2024 · PMID 39344113